Advantage Alpha Capital Partners LP Has $3.10 Million Holdings in RadNet, Inc. (NASDAQ:RDNT)

Advantage Alpha Capital Partners LP decreased its holdings in RadNet, Inc. (NASDAQ:RDNT) by 22.6% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 44,642 shares of the medical research company’s stock after selling 13,004 shares during the quarter. Advantage Alpha Capital Partners LP’s holdings in RadNet were worth $3,098,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in shares of RadNet by 3.2% during the 2nd quarter. AQR Capital Management LLC now owns 5,131 shares of the medical research company’s stock worth $302,000 after buying an additional 160 shares during the last quarter. Chartwell Investment Partners LLC lifted its position in RadNet by 0.8% during the third quarter. Chartwell Investment Partners LLC now owns 24,883 shares of the medical research company’s stock worth $1,726,000 after acquiring an additional 193 shares during the last quarter. Crossmark Global Holdings Inc. boosted its holdings in shares of RadNet by 6.3% during the third quarter. Crossmark Global Holdings Inc. now owns 4,958 shares of the medical research company’s stock worth $344,000 after acquiring an additional 296 shares during the period. Hanseatic Management Services Inc. grew its position in shares of RadNet by 1.8% in the second quarter. Hanseatic Management Services Inc. now owns 19,968 shares of the medical research company’s stock valued at $1,177,000 after purchasing an additional 353 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of RadNet by 74.7% during the second quarter. GAMMA Investing LLC now owns 865 shares of the medical research company’s stock worth $51,000 after purchasing an additional 370 shares during the period. 77.90% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Ranjan Jayanathan sold 38,557 shares of RadNet stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $80.00, for a total value of $3,084,560.00. Following the transaction, the insider now owns 192,724 shares in the company, valued at approximately $15,417,920. This trade represents a 16.67 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.12% of the company’s stock.

RadNet Stock Down 0.7 %

Shares of NASDAQ RDNT opened at $81.47 on Tuesday. The stock has a market capitalization of $6.03 billion, a P/E ratio of -1,163.86 and a beta of 1.75. The stock’s fifty day moving average is $71.32 and its 200 day moving average is $64.41. RadNet, Inc. has a 52 week low of $32.01 and a 52 week high of $93.65. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.16 and a current ratio of 2.16.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Barclays upgraded RadNet from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $57.00 to $79.00 in a research note on Friday, September 6th. Truist Financial upped their price target on shares of RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. Jefferies Financial Group raised their price target on shares of RadNet from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, September 19th. Finally, Sidoti raised shares of RadNet to a “strong-buy” rating in a report on Friday, October 4th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $74.75.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.